Kodai Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Kodai Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$275K	Buy	+34,685	New	+$374K	0.01%	144

Other funds holding DAWN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

ECM

Estuary Capital Management Wayzata, Minnesota $598M AUM 1.72% 1-Year Est. Return

Kodai Capital Management's DAWN Position: Q1 2025 in Review

Kodai Capital Management opened a new position in Day One Biopharmaceuticals (DAWN) in Q1 2025: 34,685 shares worth $275K. The stake represents 0.01% of the portfolio and ranks #144 among its holdings.

184 funds tracked by Wall St. Rank hold DAWN as of Q1 2025.

Kodai Capital Management held 34,685 shares of Day One Biopharmaceuticals worth $275K as of Q1 2025.
Day One Biopharmaceuticals was a new Kodai Capital Management position in Q1 2025.
Day One Biopharmaceuticals made up 0.01% of Kodai Capital Management's portfolio in Q1 2025, its #144 holding.
184 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2025.

Based on Kodai Capital Management's 13F filing for Q1 2025, filed 15 May 2025.